Auric Pharma Science to acquire Neuro-Biotech - MarketLine Financial Deals

Auric Pharma Science to acquire Neuro-Biotech

Auric Pharma Science to acquire Neuro-Biotech - MarketLine Financial Deals
Auric Pharma Science to acquire Neuro-Biotech
Published Feb 09, 2011
2 pages — Published Feb 09, 2011
Price US$ 20.00  |  Buy this Report Now

About This Report

  
Abstract:

Neuro-Biotech Corporation, a Switzerland-based neuroscience medical diagnostic company, has received an unsolicited offer from Auric Pharma Science, a Spain-based company.

  
Source:
Document ID
MA51171_110218
Country
Country
Ticker
MRES=CH
Format:
PDF Adobe Acrobat
Buy Now

MarketLine Financial Deals—MarketLine Financial Deals – Identifying and tracking major financial activity across our full scope of company and sector coverage, MarketLine Financial Deals covers mergers & acquisitions, private equity/venture capital backed buyouts, investments, and exits, IPOs and secondary and follow on offerings, and private placements and exits. Additional non-corporate financial deals including partnership agreements, joint ventures, co-development and research, licensing and co-marketing agreements are also available.

About the Author


Cite this Report

  
MLA:
MarketLine Financial Deals. "Auric Pharma Science to acquire Neuro-Biotech" Feb 09, 2011. Alacra Store. Dec 03, 2016. <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Auric-Pharma-Science-to-acquire-Neuro-Biotech-2052-56345>
  
APA:
MarketLine Financial Deals. (2011). Auric Pharma Science to acquire Neuro-Biotech Feb 09, 2011. New York, NY: Alacra Store. Retrieved Dec 03, 2016 from <http://www.alacrastore.com/storecontent/MarketLine-Financial-Deals/Auric-Pharma-Science-to-acquire-Neuro-Biotech-2052-56345>
  
US$ 20.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our MarketLine Financial Deals from one place.